Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Kaminsky

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|August 10, 2014
AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancerYi Xie, Martin J Hicks, Stephen M Kaminsky, et al.
Human Gene Therapy|May 12, 2023
Assessment of Residual Full-Length SV40 Large T Antigen in Clinical-Grade Adeno-Associated Virus Vectors Produced in 293T CellsBishnu P De, Sara Cram, Hyunmi Lee, et al.
Translational Vision Science & Technology|July 27, 2021
Automated Retinal Layer Segmentation in CLN2-Associated Disease: Commercially Available Software Characterizing a Progressive MaculopathyKyle D Kovacs, Anton Orlin, Dolan Sondhi, et al.
Human Gene Therapy|April 10, 2012
In vivo gene transfer strategies to achieve partial correction of von Willebrand diseaseLan Wang, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|April 25, 2013
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccineJonathan B Rosenberg, Bishnu P De, Martin J Hicks, et al.
Basic & Clinical Pharmacology & Toxicology|May 13, 2023
Preclinical safety and biodistribution assessment of Ad-KCNH2-G628S administered via atrial painting in New Zealand white rabbitsJanet M Benson, Gensheng Wang, Julie A Hutt, et al.
Plos One|November 30, 2020
Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine useDavid F Havlicek, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|October 30, 2013
Gene therapy to stimulate angiogenesis to treat diffuse coronary artery diseaseStephen M Kaminsky, Todd K Rosengart, Jonathan Rosenberg, et al.
Experimental Neurology|April 16, 2018
Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2Sandra Markmann, Jasmine J Christie-Reid, Jonathan B Rosenberg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 8, 2024
AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer's disease miceCaner Günaydin, Dolan Sondhi, Stephen M Kaminsky, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|August 10, 2014
AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancerYi Xie, Martin J Hicks, Stephen M Kaminsky, et al.
Human Gene Therapy|May 12, 2023
Assessment of Residual Full-Length SV40 Large T Antigen in Clinical-Grade Adeno-Associated Virus Vectors Produced in 293T CellsBishnu P De, Sara Cram, Hyunmi Lee, et al.
Translational Vision Science & Technology|July 27, 2021
Automated Retinal Layer Segmentation in CLN2-Associated Disease: Commercially Available Software Characterizing a Progressive MaculopathyKyle D Kovacs, Anton Orlin, Dolan Sondhi, et al.
Human Gene Therapy|April 10, 2012
In vivo gene transfer strategies to achieve partial correction of von Willebrand diseaseLan Wang, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|April 25, 2013
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccineJonathan B Rosenberg, Bishnu P De, Martin J Hicks, et al.
Basic & Clinical Pharmacology & Toxicology|May 13, 2023
Preclinical safety and biodistribution assessment of Ad-KCNH2-G628S administered via atrial painting in New Zealand white rabbitsJanet M Benson, Gensheng Wang, Julie A Hutt, et al.
Plos One|November 30, 2020
Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine useDavid F Havlicek, Jonathan B Rosenberg, Bishnu P De, et al.
Human Gene Therapy|October 30, 2013
Gene therapy to stimulate angiogenesis to treat diffuse coronary artery diseaseStephen M Kaminsky, Todd K Rosengart, Jonathan Rosenberg, et al.
Experimental Neurology|April 16, 2018
Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2Sandra Markmann, Jasmine J Christie-Reid, Jonathan B Rosenberg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 8, 2024
AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer's disease miceCaner Günaydin, Dolan Sondhi, Stephen M Kaminsky, et al.
Pageof 7